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Clinics and pathology 
Disease 
Acute myelogenous leukemia, Therapy-related MDS 
(RAEB, RAEB-t) 
Phenotype/cell stem origin 
Myeloid, positive for CD34, 33, 13, HLA-DR. 
Etiology 
Either therapy-related or de novo. 
 
Table 1. 










Leukemic cells have characteristics of type II myeloblasts with numerous granules. Several large nucleoli are seen in nuclei.(Wright-
Giemmsa staining)(x 1,000). 
 





The NUP98 gene is fused to a number of genes through 
chromosomal translocation. The breakpoints in NUP98 
gene span six introns (intron 9-14). Of particular notice, 
one type of translocation occurs in a specific intron. As 
for t(11;20), all four cases have the breakpoint in intron 





Topoisomerase 1 is a ca.100 kDa protein with 765  
amino acids; contains NLS in the N-term, a core  
domain which recognizes its binding sequences, a link 
domain which connects the core and catalytic domains, 
and the catalytic domain in the C-term. 




NUP98-TOP1 fusion protein has been proved to be 
leukemogenic in mice. 
To be noted 
Note 
Primer sets for RT-PCR and genomic PCR have been 
published in References. 
Case Report 
Translocation t(11;20)(p15;q11) detected in AML M0: 
















Structural diagrams of NUP98, TOP1, and fused chimeras. Fused protein has N-terminal of NUP98, which contains two FG repeats, and 
the core, link and catalytic domains of TOP1. Gene product of TOP1/NUP98 (150kD) has been demonstrated, but the fused protein of 
TOP1/NUP98 has not been examined. 
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